BLTP2: Potential Drug Targets (G9703)

Target Name: BLTP2

NCBI ID: G9703

BLTP2

BLTP2: Potential Drug Targets

BLTP2 (FMP27) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the BMP-2 (basic mitochondrial protein 2) family, which is a group of proteins that are involved in the regulation of mitochondrial function and energy metabolism.

BLTP2 is unique because it is able to interact with multiple cellular signaling pathways, including the TGF-β pathway and the Wnt pathway. This means that it can influence the growth, differentiation, and survival of various cell types, making it a potentially important drug target.

One of the ways that BLTP2 is involved in these signaling pathways is by regulating the activity of the transcription factor, p21 ( transforming growth factor beta 1). This transcription factor is known for its role in promoting the development and maintenance of cancer, and it is thought to be involved in the regulation of many diseases, including cancer, neurodegenerative diseases, and developmental disorders.

By interacting with p21, BLTP2 is able to regulate its activity and influence the expression of genes that are involved in cell growth, differentiation, and survival. This means that BLTP2 may be a useful drug target for diseases that are characterized by uncontrolled cell growth or dysfunction.

Another way that BLTP2 is involved in signaling pathways is by regulating the activity of the protein, p53. This protein is known for its role in promoting the survival of cells in response to a variety of stressors, including radiation and chemotherapy. It is also involved in the regulation of cell growth and differentiation, and is thought to be involved in the development of many diseases, including cancer.

By interacting with p53, BLTP2 is able to regulate its activity and influence the expression of genes that are involved in cell growth, differentiation, and survival. This means that BLTP2 may be a useful drug target for diseases that are characterized by uncontrolled cell growth or dysfunction.

In addition to its involvement in signaling pathways, BLTP2 is also thought to be involved in the regulation of cellular processes that are important for maintaining the structure and function of cells. This includes the regulation of cell adhesion, which is the process by which cells stick together to form tissues and organs, as well as the regulation of cell migration, which is the movement of cells from one location to another.

Overall, BLTP2 is a protein that is involved in a variety of cellular processes that are important for maintaining the structure and function of cells. As a result, it is a potentially important drug target for diseases that are characterized by uncontrolled cell growth or dysfunction. Further research is needed to fully understand the role of BLTP2 in these processes and to determine its potential as a drug target.

Protein Name: Bridge-like Lipid Transfer Protein Family Member 2

Functions: Tube-forming lipid transport protein which binds to phosphatidylinositols and affects phosphatidylinositol-4,5-bisphosphate (PtdIns-4,5-P2) distribution

The "BLTP2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BLTP2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets